Population-Wide Screening for Chronic Kidney Disease

医学 肾脏疾病 人口 队列 质量调整寿命年 成本效益 透析 全国健康与营养检查调查 重症监护医学 医疗补助 内科学 儿科 医疗保健 环境卫生 经济 风险分析(工程) 经济增长
作者
Marika Cusick,Rebecca L. Tisdale,Glenn M. Chertow,Douglas K Owens,Jeremy D. Goldhaber‐Fiebert
出处
期刊:Annals of Internal Medicine [American College of Physicians]
卷期号:176 (6): 788-797 被引量:48
标识
DOI:10.7326/m22-3228
摘要

Background: Sodium–glucose cotransporter-2 (SGLT2) inhibitors have the potential to alter the natural history of chronic kidney disease (CKD), and they should be included in cost-effectiveness analyses of screening for CKD. Objective: To determine the cost-effectiveness of adding population-wide screening for CKD. Design: Markov cohort model. Data Sources: NHANES (National Health and Nutrition Examination Survey), U.S. Centers for Medicare & Medicaid Services data, cohort studies, and randomized clinical trials, including the DAPA-CKD (Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease) trial. Target Population: Adults. Time Horizon: Lifetime. Perspective: Health care sector. Intervention: Screening for albuminuria with and without adding SGLT2 inhibitors to the current standard of care for CKD. Outcome Measures: Costs, quality-adjusted life-years (QALYs), and incremental cost-effectiveness ratios (ICERs), all discounted at 3% annually. Results of Base-Case Analysis: One-time CKD screening at age 55 years had an ICER of $86 300 per QALY gained by increasing costs from $249 800 to $259 000 and increasing QALYs from 12.61 to 12.72; this was accompanied by a decrease in the incidence of kidney failure requiring dialysis or kidney transplant of 0.29 percentage points and an increase in life expectancy from 17.29 to 17.45 years. Other options were also cost-effective. During ages 35 to 75 years, screening once prevented dialysis or transplant in 398 000 people and screening every 10 years until age 75 years cost less than $100 000 per QALY gained. Results of Sensitivity Analysis: When SGLT2 inhibitors were 30% less effective, screening every 10 years during ages 35 to 75 years cost between $145 400 and $182 600 per QALY gained, and price reductions would be required for screening to be cost-effective. Limitation: The efficacy of SGLT2 inhibitors was derived from a single randomized controlled trial. Conclusion: Screening adults for albuminuria to identify CKD could be cost-effective in the United States. Primary Funding Source: Agency for Healthcare Research and Quality, Veterans Affairs Office of Academic Affiliations, and National Institute of Diabetes and Digestive and Kidney Diseases.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小小鱼完成签到 ,获得积分10
1秒前
1秒前
甜美砖家完成签到 ,获得积分10
3秒前
superspace完成签到,获得积分10
4秒前
nn发布了新的文献求助10
6秒前
求助完成签到,获得积分10
7秒前
8秒前
翁雁丝完成签到 ,获得积分10
15秒前
郭义敏完成签到,获得积分0
15秒前
gyf完成签到,获得积分10
18秒前
李保龙完成签到 ,获得积分10
19秒前
23秒前
LJJ完成签到 ,获得积分10
24秒前
量子星尘发布了新的文献求助10
27秒前
阿姨洗铁路完成签到 ,获得积分10
32秒前
抹不掉的记忆完成签到,获得积分10
34秒前
34秒前
余杭村王小虎完成签到,获得积分10
35秒前
韭黄完成签到,获得积分20
39秒前
jeffrey完成签到,获得积分10
39秒前
Rondab应助机灵枕头采纳,获得10
45秒前
佳无夜完成签到,获得积分10
50秒前
摆哥完成签到,获得积分10
54秒前
66完成签到,获得积分10
59秒前
zlqq完成签到 ,获得积分10
59秒前
Hardskills发布了新的文献求助10
1分钟前
1分钟前
之_ZH完成签到 ,获得积分10
1分钟前
gds2021完成签到 ,获得积分10
1分钟前
你好呀嘻嘻完成签到 ,获得积分10
1分钟前
梅特卡夫完成签到,获得积分10
1分钟前
熊雅完成签到,获得积分10
1分钟前
1分钟前
睡到自然醒完成签到 ,获得积分10
1分钟前
cis2014完成签到,获得积分10
1分钟前
独特的大有完成签到 ,获得积分10
1分钟前
量子星尘发布了新的文献求助10
1分钟前
1分钟前
xingyi完成签到,获得积分10
1分钟前
1分钟前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038112
求助须知:如何正确求助?哪些是违规求助? 3575788
关于积分的说明 11373801
捐赠科研通 3305604
什么是DOI,文献DOI怎么找? 1819255
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022